Taking on H5N1

NIH announced that a vaccine for H5N1 avian flu designed by scientists at the National Institute of Allergy and Infectious Diseases has entered clinical trials. The DNA-based vaccine is the first to start human trials, according to NIH. If all goes well with this vaccine, it could help pave the way for development of other DNA-based, rather than virus-based, vaccines.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.